• Skip to primary navigation
  • Skip to main content
  • Skip to primary navigation
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
College of Medicine: Department of Biomedical Informatics
  • UAMS Health
  • Jobs
  • Giving
  • About Us
    • Employment
    • News
    • Links
    • Department Intranet
  • Faculty
    • Primary Faculty
    • Secondary Faculty
    • Adjunct Faculty
  • Staff
  • Education
    • Admission Information
    • Student Funding Opportunities
    • Graduate Programs
    • Current Course Offerings
    • DBMI FAQs
    • Research & Application Seminar
    • Recorded Sessions for CME Credit
  • INBRE
    • INBRE Bioinformatics Core Support Request Form
  • Research Labs
    • Publications
    • Arkansas Center for Genomic & Ecological Medicine (ArC-GEM)
    • Arkansas Clinical Data Repository (AR-CDR)
    • Biomedical Ontologies Arkansas (BOAR)
  • Clinical Informatics Fellowship
    • Fellowship Overview
    • Training Sites
    • Faculty
    • Current Fellows
    • Welcome to Little Rock!
  • Databases
  • Diversity, Equity, and Inclusion
    • About DBMI-DEI
    • DBMI-DEI Committee Members
    • DBMI-DEI Resources
    • DBMI-DEI Committee Events
  1. University of Arkansas for Medical Sciences
  2. College of Medicine
  3. Department of Biomedical Informatics
  4. News
  5. RNA-Seq Analysis of Spinal Cord Tissues from hPFN1G118V Transgenic Mouse Model of ALS at Pre-symptomatic and End-Stages of Disease

RNA-Seq Analysis of Spinal Cord Tissues from hPFN1G118V Transgenic Mouse Model of ALS at Pre-symptomatic and End-Stages of Disease

Barham C1, Fil D1,2, Byrum SD3, Rahmatallah Y4, Glazko G4, Kiaei M5,6,7.

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that leads to the loss of motor neurons. The molecular mechanisms of motor neuron degeneration are largely unknown and there are currently no effective therapies to treat this disease. In this work, we report whole transcriptome profiling of spinal cords of mutant transgenic hPFN1G118V mice and their wildtype transgenic hPFN1WT controls at a pre-symptomatic stage and at the end-stage of disease. Analyses revealed that end-stage hPFN1G118V mice had 890 differentially expressed genes (747 up-regulated, 143 down-regulated) when compared to pre-symptomatic hPFN1G118V mice, and they had 836 differentially expressed genes (742 up-regulated, 94 down-regulated) when compared to age-matched hPFN1WT controls. Pre-symptomatic hPFN1G118Vmice were not significantly different from age-matched hPFN1WT controls. Ingenuity Pathway Analysis identified inflammatory pathways significantly activated in end-stage hPFN1G118V samples, suggesting an excess of glial activation at end-stage disease, possibly due to an increase in glial composition within the spinal cord during disease progression. In conclusion, our RNA-Seq data identified molecules and pathways involved in the mechanisms of neurodegeneration that could potentially serve as therapeutic targets for ALS.

PMID: 30213953 | PMCID: PMC6137178 | DOI: 10.1038/s41598-018-31132-y

Posted by Chris Lesher on September 13, 2018

Filed Under: Publications Tagged With: ALS, rna-seq, spinal cord tissues, transgenic mouse model

UAMS College of Medicine LogoUAMS College of MedicineUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2023 University of Arkansas for Medical Sciences